FDA Says No to Skin Cure, Chaos Ensues—Oops!
In a totally thrilling plot twist, the FDA's top cancer drug regulator decisively rejected Replimune Group's skin cancer therapy. STAT reveals the regulator 'played a key role' in blocking this treatment, proving once again that the path to progress is paved with perfectly timed bureaucratic pauses. Imagine the excitement as we watch how 'everything happens for a reason!' At least now, everyone has a chance to sharpen their patience skills and policymakers get to throw a bigger, better brainstorming party. What a blessing for the community spirit!
Share the Story
(1 of 3)When the FDA takes 'skin-deep' approvals seriously and says NO, who knew disappointment could feel like a plot twist in a soap opera? Buckle up, new opportunities for thrilling delays incoming! #EverythingHappensForAReason
Rejected skin cancer therapy? That's just the FDA's way of saying, 'Surprise! More paperwork, please!' Isn't life just AMAZING?!
FDA blockers: the unsung heroes of 'not today, innovation.' At least now, cancer therapies get a waitlist longer than your favorite band's reunion tour.
Source: Statnews | Published: 8/4/2025 | Author: Adam Feuerstein
More Articles in Health
Army Launches 9-1-1 Hotline Because Soldiers Really Love Calling IT
Microsoft Finally Lets Windows 11 Fans Stop Pretending to Use ViVeTool
Epstein Survivors Declare 'Done' While Melania Passes the Buck Faster Than a Baton
Telehealth Startup Outsources Doctors to AI and Angolan Phone Lines
Widow Turns Frozen Sperm Time Capsule Into Baby After 10-Year Hiatus
OpenAI CEO Temporarily Downgrades from AI Overlord to Human POTS Patient
Woman Quits Job at 38 to Audit Diaper Changing as Full-Time Gig
Utah Lets Robot Shrink Prescribe Meds, Because What Could Go Wrong?
